Peru Pharmaceuticals and Healthcare Report Q4 2009

Executive Summary .5
SWOT Analysis6
Peru: Pharmaceuticals And Healthcare Industry SWOT.. 6
Peru Political SWOT Analysis 7
Peru Economic SWOT Analysis . 7
Peru Business Environment SWOT Analysis 8
Pharmaceutical Business Environment Ratings 9
Limits Of Potential Returns 10
Risks To Realisation Of Returns . 10
Peru - Market Summary ..12
Regulatory Regime.14
Intellectual Property Regime 15
IP Shortcomings.. 15
Counterfeit Pharmaceuticals 16
Trade Agreements.. 17
Pricing Regime 18
Government Tenders. 19
Reimbursement Regime 21
Other Regulatory Issues.. 21
Industry Developments23
Epidemiology 23
Non-Communicable Diseases .. 24
Communicable Diseases . 25
Recent Public Health Developments . 26
Healthcare Sector .. 26
Healthcare Provision 27
Table - Key Goals of Parsalud II in Nine Regions* .. 28
Health Insurance 28
Pharmaceutical Sector. 29
Recent Company Activity 30
Pharmaceutical Distribution And Retail . 32
Clinical Trials.. 33
Medical Devices.. 33
Industry Forecast Scenario 35
Overall Market Forecast. 35
Table: Peru – Drug Market Indicators, Historical Data and Forecasts .. 36
Key Growth Factors – Industry 37
Table: Peru – Health Expenditure Indicators, Historical Data and Forecasts . 38
Key Growth Factors – Macroeconomic .. 39
Table: Peru – Economic Activity, 2006-2013 .. 40
Prescription Market Forecast .. 41
Table: Peru – Prescription Drug Market Indicators, Historical Data and Forecasts (US$mn unless otherwise indicated).. 42
Patented Market Forecast.. 43
Table: Peru – Patented Market Indicators, Historical Data and Forecasts 44
Generics Market Forecast . 45
Table: Peru – Generic Market Indicators, Historical Data and Forecasts . 46
OTC Market Forecast.. 47
Table: Peru – OTC Market Indicators, Historical Data and Forecasts (US$mn unless otherwise stated) . 48
Pharmaceutical Trade Forecasts 49
Table: Peru – Pharmaceutical Trade Indicators, Historical Data and Forecasts (US$mn) .. 50
Medical Devices Forecasts 51
Table: Peru – Medical Device Market Indicators, Historical Data and Forecasts (US$mn unless otherwise indicated) 51
Other Healthcare Data Forecasts.. 52
Table: Peru – Other Healthcare Data Indicators, Historical Data and Forecasts . 52
Key Risks To BMI’s Forecast Scenario 53
Competitive Landscape..55
Table: Peruvian Pharmaceutical Companies That Acquired GMP Accreditation In 2006 . 56
Company Profiles57
Leading Multinationals.. 57
Sanofi-Aventis.. 57
Merck & Co .. 58
GlaxoSmithKline. 59
Novartis .. 60
Pfizer 61
AstraZeneca.. 62
Indigenous Manufacturer Profiles 63
Farmaindustria 63
Unimed 64
Hersil 65
Country Snapshot: Peru Demographic Data..66
Section 1: Population 66
Section 2: Education And Healthcare.. 67
Section 3: Labour Market And Spending Power . 68
Table: Consumer Expenditure, 2000-2012 (US$) .. 69
Table: Average Annual Manufacturing Wages, 2000-2012 .. 69
BMI Methodology 70
How We Generate Our Pharmaceutical Industry Forecasts . 70
Pharmaceutical Business Environment Ratings Methodology .. 71
Ratings Overview 71
Table: Pharmaceutical Business Environment Indicators . 72
Weighting 73
Table: Weighting Of Components.. 73
Sources 73